Phase II Testing focuses on what?

• A. Phase I Testing
• B. Phase III Testing
• C. Phase II Testing
• D. Placebo

Answer: (C)

Phase II testing centers on whether the drug actually works in patients who have the condition and on finding the right dose. After Phase I has shown the drug is reasonably safe and how it behaves in the body, Phase II enrolls patients to assess therapeutic efficacy while continuing to collect safety data. This phase often explores multiple doses to map the dose–response relationship and identify a dose that offers the best balance of benefit and risk, sometimes divided into IIa (early safety/efficacy signals) and IIb (larger-scale efficacy). The activities here are distinct from Phase I, which focuses on safety and pharmacokinetics in small groups, and from Phase III, which confirms efficacy and safety in a much larger population. Placebo serves as a control in trials but is not itself a development phase.